2026 NPPES data Single Specialty Group NPI 1437311487 M.D.
Verify on CMS →

MUHAMMAD FAROOQ QURESHI, M.D.

Single Specialty Group in BRENTWOOD, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 277 beneficiaries · Single Specialty Group avg: 7K
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$122.81
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MUHAMMAD FAROOQ QURESHI, M.D. filed 6,002 Medicare Part D claims in 2023 as a Single Specialty Group in BRENTWOOD, New York, prescribing 91% generic.

6K
Part D claims, 2023
91%
generic prescribing
$122.81
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MUHAMMAD FAROOQ QURESHI, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

6,002 Top 5% higher than 95% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MUHAMMAD FAROOQ QURESHI, M.D.?

Quality data not reported

NPI registry status

Active

Issued 07/01/2008

NPI 1437311487

Primary specialty

Single Specialty Group

Rare

24 US NPIs in this specialty

Medicare Part D claims

6,002 16% vs specialty avg

2023 prescription claims

Specialty avg: 7,180

Specialty distribution in New York

How Single Specialty Group compares to other specialties among New York providers

New York providers

Single Specialty Group share within New York

1. Single Specialty Group42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Single Specialty Group share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Single Specialty Group (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Single Specialty Group ABMS/AOA estimate

Est. board-certified rate (Single Specialty Group) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Single Specialty Group) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MUHAMMAD FAROOQ QURESHI, M.D. appears in the CMS NPPES registry as a Single Specialty Group provider holding M.D. credentials at 146 3RD AVE, BRENTWOOD, NY, 11717, with a listed phone of (631) 665-2910. NPI 1437311487 was issued on 07/01/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what QURESHI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 6,002 prescription claims written by this provider, covering 277 Medicare beneficiaries and totaling roughly $433K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Single Specialty Group is a narrow specialty nationwide, with 24 enrolled providers across 16 states and an average of 7,180 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

146 3RD AVE
BRENTWOOD, NY 11717

Provider Details

NPI 1437311487
Specialty Single Specialty Group
Credentials M.D.
Gender Male
NPI Issued 07/01/2008

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MUHAMMAD FAROOQ QURESHI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$123

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MUHAMMAD FAROOQ QURESHI, M.D.. To verify MUHAMMAD FAROOQ QURESHI, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MUHAMMAD FAROOQ QURESHI, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 6,002 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

6,002
Total Claims
$433K
Total Drug Cost
277
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
10,307
Total Day Supply
302,958
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$306K
Generic Drug Cost
$112K
Antibiotic Claims
54

Patient Demographics

Average Patient Age
69.9 years
Avg HCC Risk Score
1.03
Gender Split
48% female / 52% male
Age Distribution
<65: 33, 65-74: 183, 75-84: 50, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MUHAMMAD FAROOQ QURESHI, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
539
Metformin Hcl
289
Losartan Potassium
274
Amlodipine Besylate
249
Rosuvastatin Calcium
220
Metformin Hcl Er
Metformin Hcl
172
Famotidine
169
Lisinopril
168
Hydrochlorothiazide
163
Levothyroxine Sodium
154

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Single Specialty Group Overview

How MUHAMMAD FAROOQ QURESHI, M.D. fits within the Single Specialty Group landscape nationally.

24
Single Specialty Group Providers in US
16
States with Single Specialty Group
7,180
Avg Claims per Provider

MUHAMMAD FAROOQ QURESHI, M.D.'s 6,002 claims are below the specialty average of 7,180.

Nearby Single Specialty Group Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as QURESHI.

Compare Single Specialty Group nationally: see state-by-state distribution →

Frequently Asked Questions

What is MUHAMMAD FAROOQ QURESHI, M.D.'s specialty?
MUHAMMAD FAROOQ QURESHI, M.D. specializes in Single Specialty Group and practices in BRENTWOOD, New York. Credentials: M.D..
How much does MUHAMMAD FAROOQ QURESHI, M.D. prescribe under Medicare Part D?
In 2023, MUHAMMAD FAROOQ QURESHI, M.D. wrote 6,002 Medicare Part D claims totaling $433K in drug costs for 277 beneficiaries.
Where is MUHAMMAD FAROOQ QURESHI, M.D. located?
MUHAMMAD FAROOQ QURESHI, M.D. is located at 146 3RD AVE, BRENTWOOD, NY, 11717. Phone: (631) 665-2910.
What is MUHAMMAD FAROOQ QURESHI, M.D.'s NPI number?
MUHAMMAD FAROOQ QURESHI, M.D.'s National Provider Identifier (NPI) is 1437311487, issued on 07/01/2008.
Does MUHAMMAD FAROOQ QURESHI, M.D. prescribe more brand-name or generic drugs?
MUHAMMAD FAROOQ QURESHI, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $306K in brand drug costs.
How many Single Specialty Group providers are there in the US?
There are 24 Single Specialty Group providers across 16 states in the US. The average Single Specialty Group provider writes 7,180 Medicare Part D claims per year.
What drugs does MUHAMMAD FAROOQ QURESHI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MUHAMMAD FAROOQ QURESHI, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Metformin Hcl, Losartan Potassium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MUHAMMAD FAROOQ QURESHI, M.D. accept Medicare?
MUHAMMAD FAROOQ QURESHI, M.D. appears in CMS Medicare data with 6,002 Part D claims and 277 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MUHAMMAD FAROOQ QURESHI, M.D.'s credentials?
MUHAMMAD FAROOQ QURESHI, M.D.'s NPI is 1437311487 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology